-+ 0.00%
-+ 0.00%
-+ 0.00%

Japan Grants Orphan Drug Designation to Dyne Therapeutics' Zeleciment Basivarsen for Myotonic Dystrophy Type 1

Reuters·01/20/2026 12:30:48

Please log in to view news